Naltrexone Completed Phase 3 Trials for Opioid Dependence Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01717963Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway